These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17588496)

  • 41. Multi-drug resistant tuberculosis in Chuuk State Federated States of Micronesia, 2008-2009.
    Fred D; Desai M; Song R; Bamrah S; Pavlin BI; Heetderks A; Ekiek MJ
    Pac Health Dialog; 2010 Apr; 16(1):123-7. PubMed ID: 20968244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multiple drug resistance: a threat for tuberculosis control].
    Cardoso EM
    Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scientific basis of directly observed treatment, short-course (DOTS).
    Sharma SK; Mohan A
    J Indian Med Assoc; 2003 Mar; 101(3):157-8, 166. PubMed ID: 14603962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tuberculosis: steady dynamics between past and present to imagine the future].
    Cabello C F
    Rev Med Chil; 2011 Jul; 139(7):829-32. PubMed ID: 22051818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Developmental status of new antituberculous drugs].
    Igarashi M; Takahashi Y
    Nihon Rinsho; 2011 Aug; 69(8):1482-8. PubMed ID: 21838051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The national tuberculosis drug resistance survey in Cambodia, 2000-2001.
    Yamada N; Saorith K; Yamakami K; Onozaki I; Boran S; Fujiki A; Eang MT; Mori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1321-7. PubMed ID: 18034953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TB: the leading infectious killer of adults and the single biggest killer of young women. Three million deaths; seven million new cases in 1997.
    UN Chron; 1999; 36(1):18. PubMed ID: 12295238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Styblo model 20 years later: what holds true?
    Arnadottir T
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):672-90. PubMed ID: 19460242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polish up on past pestilence and present pathogens.
    Schofield CB
    MLO Med Lab Obs; 2008 Jun; 40(6):20, 22-5, 47. PubMed ID: 18630097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asia: fastest growing AIDS problem.
    Reprowatch; 1998 Nov 16-30; 17(4):1-2. PubMed ID: 12348871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control.
    Fair E; Hopewell PC; Pai M
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):61-5. PubMed ID: 17266454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNTCP 2007: looking ahead to future challenges.
    Chauhan LS
    J Indian Med Assoc; 2007 Apr; 105(4):192, 194, 196. PubMed ID: 17822187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fight against tuberculosis in the world].
    El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
    Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.